Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2003
08/28/2003US20030161821 Pharmaceutical composition
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161811 Method for treating cervical cancer
08/28/2003US20030161809 Complexes; drug delivery
08/28/2003US20030161797 Method of reducing and treating UVB-induced immunosuppression
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2486381A1 Lipase inhibiting composition
08/28/2003CA2477191A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003CA2476956A1 Strategy for retroviral immunotherapy
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476832A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476771A1 A preparation and method for weight reduction
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475923A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003CA2475374A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
08/28/2003CA2474671A1 Methods for determining the influence of protein binding on antiretroviral activity
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2468631A1 Prostaglandin composition for the treatment of erectile dysfunction
08/27/2003EP1337859A1 Selective anxiolytic therapeutic agents
08/27/2003EP1337854A2 Method for screening anti-proliferative compounds and inhibiting tumor growth
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337285A1 Implants with a phosphazene-containing coating
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337274A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
08/27/2003EP1337273A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
08/27/2003EP1337272A2 Combination of gaba agonists and aldose reductase inhibitors
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337263A1 A composition or rose hip and fish oil for alleviating joint pain and stiffness
08/27/2003EP1337257A1 Use of neuropeptide-y antagonists in treatment of alcoholism
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337250A2 Use of p38 inhibitors for the treatment of smoke inhalation
08/27/2003EP1337248A1 Methods for treatment of inflammatory diseases
08/27/2003EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
08/27/2003EP1337243A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
08/27/2003EP1337236A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
08/27/2003EP1337234A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
08/27/2003EP1337233A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling
08/27/2003EP1337228A2 Compositions for removing human cerumen
08/27/2003EP1337149A2 Vaccine immunotherapy for immune suppressed patients
08/27/2003EP1237569B1 An additive for an animal feed
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP0988057B1 Bioreductive conjugates for drug targeting
08/27/2003EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
08/27/2003EP0885005B1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
08/27/2003EP0735881B1 Means and method for hormonal contraception and/or the treatment of acne
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438900A A Novel treatment for cough
08/27/2003CN1438897A Remedial agent for anxiety neurosis or depression and piperazine derivative
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438886A Ophthalmic solution
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/27/2003CN1438880A Method for preparing a composition
08/27/2003CN1438878A Topical pharmaceutical formulations and methods of treatment
08/27/2003CN1438866A Medical product package for eradication therapy
08/27/2003CN1438313A Method for preparing microcapsulized functional cell
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119146C Compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/27/2003CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610746 Treating non-insulin dependent diabetes mellitus, insulin resistance, Syndrome X, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, polycystic ovary syndrome, cataracts and hyperglycemia; kits
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610735 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide)
08/26/2003US6610728 Method for treatment of non-rheumatoid arthritis
08/26/2003US6610722 Inhibitors of prenyl-protein transferase
08/26/2003US6610719 Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure
08/26/2003US6610713 Treating cell with cholinergic agonist
08/26/2003US6610699 Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
08/26/2003US6610690 Administering optically pure (S,S) enantiomer of reboxetine
08/26/2003US6610682 Comprising insulin resistance improving agents in combination with drugs selected from angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors with a diluent or carrier
08/26/2003US6610681 Neurotherapeutic clavulanate composition and method
08/26/2003US6610652 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610331 Kit for enhancing the natural fertility process. The kit includes a vaginal douche that is used prior to intercourse to enhance the sperm transportation and sustaining properties of the cervical mucous. The douche contains an electrolyte
08/26/2003US6610328 Amoxicillin-clarithromycin antibiotic composition
1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 1151